HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Appel, H. Articles by Wucherpfennig, K. W. Search for Related Content PubMed PubMed Citation Articles by Appel, H. Articles by Wucherpfennig, K. W.

Anergy Induction by Dimeric TCR Ligands¹

Heiner Appel^*, Nilufer P. Seth^*, Laurent Gauthier^* and Kai W. Wucherpfennig^2,*,

^* Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, and Department of Neurology, Harvard Medical School, Boston, MA 02115

T cells that recognize particular self Ags are thought to be important in the pathogenesis of autoimmune diseases. In multiple sclerosis, susceptibility is associated with HLA-DR2, which can present myelin-derived peptides to CD4⁺ T cells. To generate molecules that target such T cells based on the specificity of their TCR, we expressed a soluble dimeric DR2-IgG fusion protein with a bound peptide from myelin basic protein (MBP). Soluble, dimeric DR2/MBP peptide complexes activated MBP-specific T cells in the absence of signals from costimulatory or adhesion molecules. This initial signaling through the TCR rendered the T cells unresponsive (anergic) to subsequent activation by peptide-pulsed APCs. Fluorescent labeling demonstrated that anergic T cells were initially viable, but became susceptible to late apoptosis due to insufficient production of cytokines. Dimerization of the TCR with bivalent MHC class II/peptide complexes therefore allows the induction of anergy in human CD4⁺ T cells with a defined MHC/peptide specificity.

This article has been cited by other articles:

				J. Huan, L. J. Kaler, J. L. Mooney, S. Subramanian, C. Hopke, A. A. Vandenbark, E. F. Rosloniec, G. G. Burrows, and H. Offner MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis J. Immunol., January 15, 2008; 180(2): 1249 - 1257. [Abstract] [Full Text] [PDF]

				A. P. Fontenot, T. S. Keizer, M. McCleskey, D. G. Mack, R. Meza-Romero, J. Huan, D. M. Edwards, Y. K. Chou, A. A. Vandenbark, B. Scott, et al. Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4+ T Cells J. Immunol., September 15, 2006; 177(6): 3874 - 3883. [Abstract] [Full Text] [PDF]

				G. S. Angelov, P. Guillaume, M. Cebecauer, G. Bosshard, D. Dojcinovic, P. Baumgaertner, and I. F. Luescher Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity J. Immunol., March 15, 2006; 176(6): 3356 - 3365. [Abstract] [Full Text] [PDF]

				B. Dzhambazov, K. S. Nandakumar, J. Kihlberg, L. Fugger, R. Holmdahl, and M. Vestberg Therapeutic Vaccination of Active Arthritis with a Glycosylated Collagen Type II Peptide in Complex with MHC Class II Molecules J. Immunol., February 1, 2006; 176(3): 1525 - 1533. [Abstract] [Full Text] [PDF]

				R. Mallone, S. A. Kochik, H. Reijonen, B. Carson, S. F. Ziegler, W. W. Kwok, and G. T. Nepom Functional avidity directs T-cell fate in autoreactive CD4+ T cells Blood, October 15, 2005; 106(8): 2798 - 2805. [Abstract] [Full Text] [PDF]

				Z. Karabekian, S. D. Lytton, P. B. Silver, Y. V. Sergeev, J. P. Schneck, and R. R. Caspi Antigen/MHC Class II/Ig Dimers for Study of Uveitogenic T Cells: IRBP p161-180 Presented by both IA and IE Molecules Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3769 - 3776. [Abstract] [Full Text] [PDF]

				M.-F. Pahl-Seibert, M. Juelch, J. Podlech, D. Thomas, P. Deegen, M. J. Reddehase, and R. Holtappels Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting J. Virol., May 1, 2005; 79(9): 5400 - 5413. [Abstract] [Full Text] [PDF]

				R. Mallone, S. A. Kochik, E. M. Laughlin, V. H. Gersuk, H. Reijonen, W. W. Kwok, and G. T. Nepom Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells Diabetes, April 1, 2004; 53(4): 971 - 977. [Abstract] [Full Text] [PDF]

				E. L. Masteller, M. R. Warner, W. Ferlin, V. Judkowski, D. Wilson, N. Glaichenhaus, and J. A. Bluestone Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune Diabetes J. Immunol., November 15, 2003; 171(10): 5587 - 5595. [Abstract] [Full Text] [PDF]

				C. Wang, J. L. Mooney, R. Meza-Romero, Y. K. Chou, J. Huan, A. A. Vandenbark, H. Offner, and G. G. Burrows Recombinant TCR Ligand Induces Early TCR Signaling and a Unique Pattern of Downstream Activation J. Immunol., August 15, 2003; 171(4): 1934 - 1940. [Abstract] [Full Text] [PDF]

				A. A. Vandenbark, C. Rich, J. Mooney, A. Zamora, C. Wang, J. Huan, L. Fugger, H. Offner, R. Jones, and G. G. Burrows Recombinant TCR Ligand Induces Tolerance to Myelin Oligodendrocyte Glycoprotein 35-55 Peptide and Reverses Clinical and Histological Signs of Chronic Experimental Autoimmune Encephalomyelitis in HLA-DR2 Transgenic Mice J. Immunol., July 1, 2003; 171(1): 127 - 133. [Abstract] [Full Text] [PDF]

				S. Thomas, R. Kumar, A. Preda-Pais, S. Casares, and T.-D. Brumeanu A Model for Antigen-Specific T-Cell Anergy: Displacement of CD4-p56lck Signalosome from the Lipid Rafts by a Soluble, Dimeric Peptide-MHC Class II Chimera J. Immunol., June 15, 2003; 170(12): 5981 - 5992. [Abstract] [Full Text] [PDF]